Survey of the application status of FIGO clinical staging system in cervical cancer in China between 2004 and 2016
ZHANG Wei-feng
LI Peng-fei
CHEN Chun-lin
LIU Ping
YANG Ying
HAO Min
ZHAO Wei-dong
LU Anwei
ZHU Qian-yong
DAI En-cheng
NI Yan
CHEN Long
LANG Jing-he
Abstract：Objective To investigate the application status of FIGO clinical staging system in cervical cancer in China.Methods A total of 31 599 cases of cervical cancer during the period from January 2004 to December 2016 were retrospectively reviewed.The original clinical stages were recorded and entered into a database.The standardized degree of clinical stage was evaluated by referring to the corresponding FIGO clinical staging system.Results Among the 31 599 cases,16 044(50.8％)were from general hospitals,13 822 (43.7％) from special tumor hospitals and 1733 (5.5％)from special women and children's hospitals.Non-standard application of FIGO clinical staging system were found in 6020 cases.Incomplete clinical staging (3265,54.24％) and no clinical staging(2395,39.78％)were the two most common forms of non-standard application,followed by discordance with gynecologic examination (182,3.02％);ambiguous staging such as Ⅰ B2-Ⅱ A 1,et al (102,1.69％) and stage revision postoperatively (76,1.26％).Based on analyses of associated factors,we found that age＞ 60 was associated positively with non-standard application of FIGO clinical staging(20.75％ vs.18.52％ vs.19.39％,P＜O.001);Exogenous growth pattern and maternal health care hospital were associated negatively with non-standard application of FIGO clinical staging (3.75％ vs.14.53％ vs.24.58％,P＜0.001).Conclusion Non-standard application of FIGO clinical stage was not uncommon and it occurrs more frequently in difficult situations such as old patients or non-exogenous growth patterns.
Keywords：cervical carcinomaclinical stagingapplication status
Publication Date：2018-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 67-71 )